Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient

BackgroundVaccines were developed and deployed to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to characterize patterns in the protection provided by the BNT162b2 and mRNA-1273 mRNA vaccines against a spectrum of SARS-CoV-2 infection symptoms and se...

Full description

Saved in:
Bibliographic Details
Main Author: Layan, Sukik (author)
Other Authors: Chemaitelly, Hiam (author), Ayoub, Houssein H. (author), Coyle, Peter (author), Tang, Patrick (author), Yassine, Hadi M. (author), Al Thani, Asmaa A. (author), Hasan, Mohammad R. (author), Al-Kanaani, Zaina (author), Al-Kuwari, Einas (author), Jeremijenko, Andrew (author), Kaleeckal, Anvar Hassan (author), Latif, Ali Nizar (author), Shaik, Riyazuddin Mohammad (author), Abdul-Rahim, Hanan F. (author), Nasrallah, Gheyath K. (author), Al-Kuwari, Mohamed Ghaith (author), Butt, Adeel A. (author), Al-Romaihi, Hamad Eid (author), Al-Thani, Mohamed H. (author), Al-Khal, Abdullatif (author), Bertollini, Roberto (author), Abdel-Rahman, Manar E. (author), Abu-Raddad, Laith J. (author)
Format: article
Published: 2024
Subjects:
Online Access:http://dx.doi.org/10.1016/j.vaccine.2024.04.026
https://www.sciencedirect.com/science/article/pii/S0264410X24004407
http://hdl.handle.net/10576/55352
Tags: Add Tag
No Tags, Be the first to tag this record!